All Stories

  1. Ensuring the collection of high-quality dried blood spot samples across multisite clinical studies
  2. From patient to tube: the importance of physiologically relevant quantitative bioanalytical assays
  3. Issues facing the bioanalytical community: summary of round table discussions
  4. The current skills gaps in analytical sciences are failing industry: debate at the 21st International Reid Bioanalytical Forum
  5. An investigation of the comparability of commercially sourced plasma and pharmaceutical study plasma, using total protein concentration
  6. Optimization of an automated IS addition system for use in high-throughput quantitative DBS analysis
  7. DBS and beyond
  8. DBS direct elution: optimizing performance in high-throughput quantitative LC–MS/MS analysis
  9. Investigation of Different Approaches to Incorporating Internal Standard in DBS Quantitative Bioanalytical Workflows and Their Effect on Nullifying Hematocrit-Based Assay Bias
  10. Attractive Design: An Elution Solvent Optimization Platform for Magnetic-Bead-based Fractionation Using Digital Microfluidics and Design of Experiments
  11. Quantitative bioanalysis of paracetamol in rats using volumetric absorptive microsampling (VAMS)
  12. A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit
  13. Direct Ionization of Solid-Phase Microextraction Fibers for Quantitative Drug Bioanalysis: From Peripheral Circulation to Mass Spectrometry Detection
  14. Reducing pre-clinical blood volumes for toxicokinetics: toxicologists, pathologists and bioanalysts unite
  15. EBF: reflection on bioanalytical assay requirements used to support liquid microsampling
  16. Volumetric Absorptive Microsampling: A Dried Sample Collection Technique for Quantitative Bioanalysis
  17. European Bioanalysis Forum continued plans to support liquid microsampling
  18. Pharmaceutical Perspectives of Use of Dried Blood Spots
  19. Integrating internal and external bioanalytical support to deliver a diversified pharmaceutical portfolio
  20. Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies
  21. Multiplexed extraction and quantitative analysis of pharmaceuticals from DBS samples using digital microfluidics
  22. Preliminary investigation into the use of a real-time PCR method for the quantification of an oligonucleotide in human plasma and the development of novel acceptance criteria
  23. Assessment of the within- and between-lot variability of Whatman™ FTA® DMPK and 903® DBS papers and their suitability for the quantitative bioanalysis of small molecules
  24. In-depth study of homogeneity in DBS using two different techniques: results from the EBF DBS-microsampling consortium
  25. Effect of ambient humidity on the rate at which blood spots dry and the size of the spot produced
  26. A novel approach to capillary plasma microsampling for quantitative bioanalysis
  27. A dried blood spot update: still an important bioanalytical technique?
  28. Dried matrix spot direct analysis: evaluating the robustness of a direct elution technique for use in quantitative bioanalysis
  29. Method of Applying Internal Standard to Dried Matrix Spot Samples for Use in Quantitative Bioanalysis
  30. Quantitative Analysis of Therapeutic Drugs in Dried Blood Spot Samples by Paper Spray Mass Spectrometry: An Avenue to Therapeutic Drug Monitoring
  31. Dried blood spots, pharmacokinetic studies and better medicines for children
  32. Rapid analysis of dried blood spot samples with sub-2-µm LC–MS/MS
  33. Dried blood spot sampling for quantitative bioanalysis: time for a revolution?
  34. Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates
  35. A glowing future for dried blood spot sampling
  36. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs
  37. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods
  38. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations
  39. Direct Quantitative Bioanalysis of Drugs in Dried Blood Spot Samples Using a Thin-Layer Chromatography Mass Spectrometer Interface
  40. Dried Blood Spots as a Sample Collection Technique for the Determination of Pharmacokinetics in Clinical Studies: Considerations for the Validation of a Quantitative Bioanalytical Method
  41. Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies
  42. Reduction of Signal Suppression Effects in ESI-MS Using a Nanosplitting Device
  43. Application of Atmospheric Pressure Ionization Time-of-Flight Mass Spectrometry Coupled with Liquid Chromatography for the Characterization of in Vitro Drug Metabolites
  44. Biological defunctionalisation of chlorophyll in the aquatic environment II: action of endogenous algal enzymes and aerobic bacteria
  45. Stable carbon isotopic correlation of individual biolipids in aquatic organisms and a lake bottom sediment
  46. Biologically mediated defunctionalization of chlorophyll in the aquatic environment—I. Senescence/decay of the diatom Phaeodactylum tricornutum
  47. THE ANALYSIS OF PLANT STERYL CONJUGATES BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY
  48. Negative ion ammonia chemical ionization and electron impact ionization mass spectrometric analysis of steryl fatty acyl esters
  49. Isolation and characterisation of intact steryl ferulates from seeds